Depopulated bovine ureteric xenograft for complex haemodialysis vascular access

European Journal of Vascular and Endovascular Surgery

Volumn 31, Issue 2, 2006, Pages 181-186

  Darby, Chris R ^a,b   Roy, D ^a   Deardon, D ^a   Cornall, A ^a  

^a Oxford Transplant Centre   (United Kingdom)

^b Department of Vascular Surgery ^*  (United Kingdom)

Author keywords

Bovine ureter; Outcome; Surgery; Tissue engineering; Vascular access

Indexed keywords

CEFUROXIME;

ADULT; AGE DISTRIBUTION; AGED; ANGIOPLASTY; ARTERY ANASTOMOSIS; ARTICLE; AUTOTRANSPLANTATION; BLOOD VESSEL FISTULA; BLOOD VESSEL GRAFT; BLOOD VESSEL OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; COW; CROSS LINKING; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT INFECTION; GRAFT PATENCY; HEMODIALYSIS PATIENT; HUMAN; MALE; PRIORITY JOURNAL; SURGICAL TECHNOLOGY; TISSUE ENGINEERING; TREATMENT OUTCOME; URETER; VASCULAR ACCESS; VASODILATATION; VEIN TRANSPLANTATION; XENOGRAFT;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ARTERIOVENOUS SHUNT, SURGICAL; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; BRACHIAL ARTERY; CATTLE; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; REOPERATION; TISSUE ENGINEERING; URETER; VASCULAR PATENCY;

EID: 30544437594     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2005.07.006     Document Type: Article

References (31)

1. US Renal Data System (USRDS) Annual Data Report: Atlas of end Stage renal disease in the United States 2004 National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
2. US Renal Data System (USRDS) Annual Data Report: Atlas of end stage renal disease in the United States 2003 National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases Bethesda, MD
3. National Kidney Foundation K/DOQI clinical practice guidelines for vascular access Am J Kidney Dis 37 Suppl 1 2001 S137-S181
4. J.A. Chazan M.R. London L.M. Pono Long-term survival of vascular accesses in a large chronic hemodialysis population Nephron 69 3 1995 228-233
5. M.E. Cinat J. Hopkins S.E. Wilson A prospective evaluation of PTFE graft patency and surveillance techniques in hemodialysis access Ann Vasc Surg 13 2 1999 191-198
6. H.I. Feldman S. Kobrin A. Wasserstein Hemodialysis vascular access morbidity J Am Soc Nephrol 7 4 1996 523-535
7. T.C. Hodges M.F. Fillinger R.M. Zwolak D.B. Walsh F. Bech J.L. Cronenwett Longitudinal comparison of dialysis access methods: Risk factors for failure J Vasc Surg 26 6 1997 1009-1019
8. J.H. Matsuura D. Rosenthal M. Clark F.W. Shuler L. Kirby M. Shotwell et al. Transposed basilic vein versus polytetrafluorethylene for brachial-axillary arteriovenous fistulas Am J Surg 176 2 1998 219-221
9. S.M. Taylor G.L. Eaves D.A. Weatherford J.C. McAlhany Jr H.E. Russell E.M. Langan 3rd Results and complications of arteriovenous access dialysis grafts in the lower extremity: A five year review Am Surg 62 3 1996 188-191
10. J.H. Matsuura K.H. Johansen D. Rosenthal M.D. Clark K.A. Clarke L.B. Kirby Cryopreserved femoral vein grafts for difficult hemodialysis access Ann Vasc Surg 14 1 2000 50-55
11. S. Surowiec The use of cryopreserved femoral vein for salvage of infected arteriovenous grafts: Early results 1998 Association of VA surgeons Baltimore, MD
12. J. Matsuura Cryopreserved human femoral vein: A new option for infected access grafts. Contemporary dialysis and nephrology p. 30-32 1999
13. P. Sabanayagam A.B. Schwartz R.R. Soricelli P. Lyons J. Chinitz A comparative study of 402 bovine heterografts and 225 reinforced expanded PTFE grafts as AVF in the ESRD patient Trans Am Soc Artif Intern Organs 26 1980 88-92
14. M.A. Enzler T. Rajmon M. Lachat F. Largiader Long-term function of vascular access for hemodialysis Clin Transplant 10 6 Pt 1 1996 511-515
15. J. Brems M. Castaneda P.J. Garvin A five-year experience with the bovine heterograft for vascular access Arch Surg 121 8 1986 941-944
16. G. Bacchini PTFE versus mesenteric bovine vein as vascular accesses in hemodialysis patients: Preliminary results of a randomized trial 2001 International Congress of the Vascular Access Society London, UK
17. G.B. Ratto P. Romano M. Truini M. Frascio S. Rovida A. Badini et al. Glutaraldehyde-tanned mandril-grown grafts as venous substitutes J Thorac Cardiovasc Surg 102 3 1991 440-447
18. G. Ratto Reply to the Editor regarding J Thorac Cardiovasc Surg 1991 J Thorac Cardiovasc Surg 107 1994 949
19. M.K. Widmer F. Aregger E. Stauffer H. Savolainen G. Heller H. Hakki et al. Intermediate outcome and risk factor assessment of bovine vascular heterografts used as AV-fistulas for hemodialysis access Eur J Vasc Endovasc Surg 27 6 2004 660-665
20. D.R. Clarke R.M. Lust Y.S. Sun K.S. Black J.D. Ollerenshaw Transformation of nonvascular acellular tissue matrices into durable vascular conduits Ann Thorac Surg 71 5 Suppl 1 2001 S433-S436
21. J.H. Matsuura K.S. Black A.B. Levitt D. Rosenthal E.D. Wellons M.T. Fallon et al. Cellular remodeling of depopulated bovine ureter used as an arteriovenous graft in the canine model J Am Coll Surg 198 5 2004 778-783
22. A.N. Sidawy R. Gray A. Besarab M. Henry E. Ascher M. Silva Jr et al. Recommended standards for reports dealing with arteriovenous hemodialysis accesses J Vasc Surg 35 3 2002 603-610
23. T. Schmitz-Rixen J. Megerman J.M. Anderson D.F. Warnock G.J. L'Italien H. Erasmi et al. Longterm study of a compliant biological vascular graft Eur J Vasc Surg 5 2 1991 149-158
24. G. Koch S. Gutschi O. Pascher H. Fruhwirth H. Glanzer Analysis of 274 omniflow vascular prostheses implanted over an eight-year period Aust N Z J Surg 67 9 1997 637-639
25. R.H. Raeder S.F. Badylak C. Sheehan B. Kallakury D.W. Metzger Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts Transpl Immunol 10 1 2002 15-24
26. S. Badylak K. Kokini B. Tullius B. Whitson Strength over time of a resorbable bioscaffold for body wall repair in a dog model J Surg Res 99 2 2001 282-287
27. D arby C, C ornall A. Clinical outcomes of a depopulated bovine ureter (Synergraft Vascular Graft model 100) used as an arteriovenous access graft. Advances in tissue engineering and biology of heart valves, Florence, Italy, 2004.
28. H.C. Rayner R.L. Pisoni B.W. Gillespie D.A. Goodkin T. Akiba T. Akizawa et al. Creation, cannulation and survival of arteriovenous fistulae: Data from the dialysis outcomes and practice patterns study Kidney Int 63 1 2003 323-330
29. K.D. Gibson D.L. Gillen M.T. Caps T.R. Kohler D.J. Sherrard C.O. Stehman-Breen Vascular access survival and incidence of revisions: A comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States renal data system dialysis morbidity and mortality study J Vasc Surg 34 4 2001 694-700
30. D. Warakaulle A. Cornall R. Uberoi C. Darby Vascular bovine ureteric grafts (VBUGS) as a novel conduit in fashioning haemodialysis fistulae 2004 RSNA Chicago, IL
31. A. Ruddle P. Lear D. Mitchell The morbidity of secondary vascular access. A life time of intervention Eur J Vasc Endovasc Surg 18 1 1999 30-34